This is a guest post from Susan K Finston, President of Finston Consulting. Do you have a response to Susan’s post? Respond in the comments section below. Given the increasing focus on microbiome technologies for better, safer therapies, and critical importance of Intellectual Property (IP) protection for their full commercialization, it is great to see the 2017 […]
This is a guest post from Michael D. Hooven, President & CEO, Enable Injections Inc. The oxpecker perches on the backs of zebras and eats the ticks and parasites that live on their skin. The bird gets its food, and the beasts get pest control. It’s an example of mutualism at its best – both parties […]
This is a guest post from Craig Stropkay. Craig is Director and Life Science Consultant at KOLgroups, LLC Reach for the stars, they said. You should definitely go get your PhD, you’d be great for it, they said. Well, I guess they did have a point. Pursuing my doctorate degree in Molecular Biology at Brandeis was […]
This is a guest post from Steve Kirsh. Steve is Founder + Managing Partner of Khameleon Group. When was the last time you used a matchmaking service? Chances are it was today. Platforms like Amazon, Airbnb, eBay and Uber (as well as the proverbial dating sites) have transformed matchmaking into an everyday adventure in which […]
This is a guest post from Mark D. Shtilerman1 and Joseph Eng Jr. Dr. Shtilerman is Senior Counsel at Deerfield Management, and Dr. Eng is Counsel at Hogan Lovells. … the very first official thing I did, in my administration … was to start a patent office; for I knew that a country without a […]
This is a guest post from Susan K Finston, President of Finston Consulting. Do you have a response to Susan’s post? Respond in the comments section below. The run-up to Christmas in Italy is a magical experience, and a great time to revisit Italian agricultural biotechnology. Readers of this irregular series may recall an earlier entry on […]
The pharmaceutical industry is regularly chastised for failing to do enough to ensure that people in low and middle-income countries have access to its medicines. Yet the real picture is actually more nuanced, according to a newly released report that finds some – but not all – drug makers are making headway. Some companies, for […]
This is a guest post from DrugPatentWatch. Do you have a response to DrugPatentWatch’s post? Respond in the comments section below. If domestic pharmaceutical distribution is complex, international distribution is considerably more complicated International growth markets for pharmaceuticals represent enormous opportunities, but they also bring their own unique challenges, including infrastructure, fragmented distribution, and a patchwork […]
This is a guest post from DrugPatentWatch. Do you have a response to DrugPatentWatch’s post? Respond in the comments section below. Pharmaceutical distributors face significant supply chain challenges Designing, implementing, and managing efficient product distribution can present pharmaceutical distributors and wholesalers with opportunities to create a long term strategic advantage. Distribution of pharmaceuticals has always been […]
As prescription drug costs continue to squeeze state budgets, a group of state health policy makers is offering some novel – and also some familiar – suggestions for coping. These include regulating the pharmaceutical industry as a utility, allowing states to operate as pharmacy benefit managers and waiving some provisions of the Medicaid program. In […]